ArticleMolecular therapy. Oncology2026
Targeting LKB1-inactivated lung cancers with a stapled peptide inhibitor of the CRTC-CREB pathway.
Xin Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
ArticleMolecular therapy. Oncology2026
Xin Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.